Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: A new frontier for treating hyperlipidemia

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Marinangeli, Christopher Pf ^a   Jones, Peter Jh ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; G PROTEIN COUPLED RECEPTOR 40; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; MURINE DERIVED OMEGA 3 FATTY ACID; NUTRACEUTICAL; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHYTOSTEROL; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

DRUG EFFICACY; DYSLIPIDEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; NONHUMAN; NOTE; PRACTICE GUIDELINE; PROTEIN EXPRESSION;

EID: 77957140629     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-76     Document Type: Note

References (43)

1. Prevalence of Metabolic Syndrome Among Adults 20 Years of Age and Over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003-2006. In National Health and Statistics Report. RB Ervin, Hyattsville 2009 1 8
2. Prevalence and specific features of metabolic syndrome in urban adult population. ZN Tokareva MN Mamedov AD Deev AA Evdokimova RG Oganov, Cardiovascular Therapy and Prevention 9 10 14
3. Hypertriglyceridemia: its etiology, effects and treatment. G Yuan KZ Al-Shali RA Hegele, CMAJ 2007 176 1113 1120 17420495
4. Hypercholesterolemia and inflammation in atherogenesis: Two sides of the same coin. D Steinberg, Molecular Nutrition & Food Research 2005 49 995 998
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). AJ Jehle, National Cholesterol Education Program National Heart, Lung, and Blood Institute, National Institutes of Health 2002
6. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr JA Spertus F Costa, Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
7. Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins. M Castro Cabezas JH de Vries AJ Van Oostrom J Iestra WA van Staveren, J Am Diet Assoc 2006 106 1564 1569 10.1016/j.jada.2006. 07.009 17000189
8. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. PJH Jones FY Ntanios M Raeini-Sarjaz CA Vanstone, American Journal of Clinical Nutrition 1999 69 1144 1150 10357732
9. History and development of plant sterol and stanol esters for cholesterol-lowering purposes. GR Thompson SM Grundy, American Journal of Cardiology 2005 96 3D 9D 10.1016/j.amjcard.2005.03.013 15992509
10. Lowering of serum cholesterol by the administration of a plant sterol. MM Best CH Duncan EJ Van Loon JD Wathen, Circulation 1954 10 201 206 13182752
11. Continuous Dose-Response Relationship of the LDL-Cholesterol-Lowering Effect of Phytosterol Intake. I Demonty RT Ras HCM van der Kniap G Duchateau L Meijer PL Zock JM Geleijnse EA Trautwein, Journal of Nutrition 2009 139 271 284 10.3945/jn.108.095125 19091798
12. Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men. TE Strandberg H Gylling RS Tilvis TA Miettinen, Atherosclerosis 2009 210 282 287 10.1016/j.atherosclerosis.2009.11. 007 19962145
13. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. J Dyerberg HO Bang, Lancet 1979 2 433 435 10.1016/S0140-6736(79)91490-9 89498
14. Fatty acid composition of the plasma lipids in Greenland Eskimos. J Dyerberg HO Bang N Hjorne, Am J Clin Nutr 1975 28 958 966 1163480
15. n-3 fatty acids and serum lipoproteins: human studies. WS Harris, Am J Clin Nutr 1997 65 1645S 1654S 9129504
16. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction - Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. R Marchioli F Barzi E Bomba C Chieffo D Di Gregorio R Di Mascio MG Franzosi E Geraci G Levantesi AP Maggioni L Mantini RM Marfisi G Mastrogiuseppe N Mininni GL Nicolosi M Santini C Schweiger L Tavazzi G Tognoni C Tucci F Valagussa, Circulation 2002 105 1897 1903 10.1161/01.CIR.0000014682. 14181.F2 11997274
17. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. F Valagussa MG Franzosi E Geraci N Mininni GL Nicolosi M Santini L Tavazzi C Vecchio R Marchioli E Bomba C Chieffo AP Maggioni C Schweiger G Tognoni F Barzi AV Flamminio RM Marfisi M Olivieri C Pera A Polidoro E Santoro R Zama L Pagliaro E Correale A Del Favero U Loi E Marubini L Campolo A Casari G Di Minno MB Donati M Galli M Gattone S Garattini M Mancini P Marino GM Santoro C Scardulla G Specchia A Cericola D Di Gregorio R Di Mascio G Levantesi L Mantini G Mastrogiuseppe C Tucci P Mocarelli R Baldinelli F Ceriotti A Colonna C Cortese G Fortunato C Franzini F Gonano MS Graziani, Lancet 1999 354 447 455 10.1016/S0140-6736(99)07072-5 10465168
18. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis. M Yokoyama H Origasa M Matsuzaki Y Matsuzawa Y Saito Y Ishikawa S Oikawa J Sasaki H Hishida H Itakura T Kita A Kitabatake N Nakaya T Sakata K Shimada K Shirato, Lancet 2007 369 1090 1098 10.1016/S0140-6736(07)60527-3 17398308
19. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. DJ Jenkins CW Kendall A Marchie DA Faulkner JM Wong R de Souza A Emam TL Parker E Vidgen KG Lapsley EA Trautwein RG Josse LA Leiter PW Connelly, JAMA 2003 290 502 510 10.1001/jama.290.4.502 12876093
20. Combined effects of a dietary portfolio of plant sterols, vegetable protein, viscous fibre and almonds on LDL particle size. B Lamarche S Desroches DJ Jenkins CW Kendall A Marchie D Faulkner E Vidgen KG Lapsley EA Trautwein TL Parker RG Josse LA Leiter PW Connelly, Br J Nutr 2004 92 657 663 10.1079/BJN20041241 15522135
21. Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. GD Norata S Raselli L Grigore K Garlaschelli D Vianello S Bertocco A Zambon AL Catapano, Atherosclerosis 2009 206 556 562 10.1016/j.atherosclerosis.2009.03.017 19376517
22. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. T Bjornheden A Babyi G Bondjers O Wiklund, Atherosclerosis 1996 123 43 56 10.1016/0021-9150(95)05770-6 8782836
23. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. S Koba T Hirano T Kondo M Shibata H Suzuki M Murakami E Geshi T Katagiri, American Heart Journal 2002 144 1026 1035 10.1067/mhj.2002.126119 12486427
24. Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants. I Gigleux DJ Jenkins CW Kendall A Marchie DA Faulkner JM Wong R de Souza A Emam TL Parker EA Trautwein KG Lapsley PW Connelly B Lamarche, Br J Nutr 2007 98 1229 1236 10.1017/S0007114507781461 17663803
25. Mechanism of action of fibrates on lipid and lipoprotein metabolism. B Staels J Dallongeville J Auwerx K Schoonjans E Leitersdorf JC Fruchart, Circulation 1998 98 2088 2093 9808609
26. Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators. R Hertz V Sheena B Kalderon I Berman J Bar-Tana, Biochem Pharmacol 2001 61 1057 1062 10.1016/S0006-2952(01)00578-0 11301038
27. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. MH Davidson, Am J Cardiol 2006 98 27i 33i 10.1016/j.amjcard.2005.12.024 16919514
28. Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. HJ Kim M Takahashi O Ezaki, J Biol Chem 1999 274 25892 25898 10.1074/jbc.274.36.25892 10464332
29. Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J Plat JA Nichols RP Mensink, J Lipid Res 2005 46 2468 2476 10.1194/jlr.M500272-JLR200 16150823
30. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. J Plat RP Mensink, FASEB J 2002 16 1248 1253 10.1096/fj.01-0718hyp 12153993
31. Lipid and lipoprotein dysregulation in insulin resistant states. RK Avramoglu H Basciano K Adeli, Clin Chim Acta 2006 368 1 19 10.1016/j.cca.2005. 12.026 16480697
32. Disordered lipid metabolism and the pathogenesis of insulin resistance. DB Savage KF Petersen GI Shulman, Physiol Rev 2007 87 507 520 10.1152/physrev.00024.2006 17429039
33. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. MO Weickert M Mohlig C Schofl AM Arafat B Otto H Viehoff C Koebnick A Kohl J Spranger AF Pfeiffer, Diabetes Care 2006 29 775 780 10.2337/diacare.29.04.06.dc05-2374 16567814
34. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. MB Schulze M Schulz C Heidemann A Schienkiewitz K Hoffmann H Boeing, Arch Intern Med 2007 167 956 965 10.1001/archinte.167.9.956 17502538
35. Metabolic cross talk between the colon and the periphery: implications for insulin sensitivity. MD Robertson, Proc Nutr Soc 2007 66 351 361 10.1017/S0029665107005617 17637087
36. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. MD Robertson AS Bickerton AL Dennis H Vidal KN Frayn, Am J Clin Nutr 2005 82 559 567 16155268
37. Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. F Isken S Klaus M Osterhoff AF Pfeiffer MO Weickert, J Nutr Biochem 2010 21 278 284 10.1016/j.jnutbio.2008.12. 012 19369060
38. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. P Steneberg N Rubins R Bartoov-Shifman MD Walker H Edlund, Cell Metab 2005 1 245 258 10.1016/j.cmet.2005.03.007 16054069
39. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. KC Maki JM McKenney MS Reeves BC Lubin MR Dicklin, Am J Cardiol 2008 102 429 433 10.1016/j.amjcard.2008.03.078 18678300
40. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. SN Blair DM Capuzzi SO Gottlieb T Nguyen JM Morgan NB Cater, Am J Cardiol 2000 86 46 52 10.1016/S0002-9149(00)00976-0 10867091
41. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. LA Simons, Am J Cardiol 2002 90 737 740 10.1016/S0002-9149(02)02600-0 12356387
42. Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial. DJ Becker RY Gordon PB Morris J Yorko YJ Gordon M Li N Iqbal, Mayo Clin Proc 2008 83 758 764 10.4065/83.7.758 18613992
43. Red yeast rice: a new hypolipidemic drug. M Journoud PJ Jones, Life Sci 2004 74 2675 2683 10.1016/j.lfs.2003.10.018 15069955